Benefit-Risk Evaluation: The Past, Present And Future
A short article by Juhaeri JUHAERI, VP & Head, Epidemiology and Benefit-Risk at Sanofi Keywords:…
Complex Regulatory Landscape Changes: A Growing Demand For Regulatory Information Management Platforms
Changes the life sciences industry is going through, resulting in digital transformation within the organisations…
How Do RA Professionals Manage Complexity and Bureaucracy at a Local and Market Level?
Narrow focus vs Global strategy concepts How to transform Regulatory Affairs to manage the increasing…
Digital Technologies Assisting Healthcare Providers in Patient Empowerment
Amplify clinical outcomes with evidenced digital and pharmaceutical interventions paired together How do new technologies…
How to Promote an “Informed Patient” Who Is Actively Searching for Clinical Trials
Involve your patients in CT from the beginning to ensure their needs are reflected in…
Ad Promo Landscape: Delivering Compliant Materials to Benefit Patients
Professional Regulations experts who work in collaboration with the Commercial and Medical Teams in order…
A Technology-Enabled Revolution in Pharma Regulatory Affairs
Pharma Businesses are operating significantly better and faster relying on data How could regulatory affairs…
Access as the Biggest Impact of Digital Healthcare For Society
Why solutions that are more outcomes-oriented should be taken more seriously? What Digital Health impacts…
Omnichannel Transformation for the Customer-Centric, Data-Driven Digitally Enabling Approach
Paving the way to commercial excellence through adjusting to consumer’s needs and understanding their behaviour.…
Prioritise Digital Solutions That Offer ‘True Innovation’ In Solid Partnership
Educate yourself and your company for a comprehensive evaluation of a potential partner How can…